日本語 >>
TOP page
Present specialized field
Journal
Presentation
（Last updated : 2026-02-02 11:26:28）
Shunichi Fujita
Department
Kawasaki Medical School Kawasaki Medical School, Department of Rheumatology,
Position
Assistant Professor
■
Present specialized field
Connective tissue disease and allergy
■
Journal
1.
2026/01/21
A case of concurrent cold agglutinin disease and C3 glomerulonephritis requiring differentiation from other iatrogenic immunodeficiency-associated lymphoproliferative disorder in a patient with rheumatoid arthritis and Sjögren's disease
2.
2026/01
Pulmonary Alveolar Proteinosis Developing during Tofacitinib Treatment for Anti–MDA5 Antibody–Positive Dermatomyositis–Associated Interstitial Lung Disease: A Case Report and Review of the Literature
3.
2025/09/01
Switching to IL-6 inhibitors or abatacept in elderly patients with rheumatoid arthritis achieving low disease activity with jak inhibitors: a pilot study
4.
2025/06/04
NK cell cytotoxicity is markedly reduced in younger patients with rheumatoid arthritis treated with JAK inhibitors
5.
2025/05/22
Coexistence of IgG4-Related Disease and Renal Anastomosing Hemangioma: A Rare Diagnostic Challenge
6.
2025/02/26
Clinical Significance of Antinuclear Antibodies in Patients with Rheumatoid Arthritis: From SETOUCHI-RA Registry
7.
2025/02/19
Case Report: Effective Management of Pulmonary Hypertension Associated With Takayasu Arteritis Through Both Immunosuppressive Therapy and Serial Balloon Pulmonary Angioplasty
8.
2024/03/21
Prognosis and prognostic factors of lung cancer complications in patients with rheumatoid arthritis
9.
2022/11/15
Acromegaly: A Rare Cause of Knee Pain
10.
2022/08
Iliopectineal bursitis
11.
2022/05/14
IL-17A promotes vascular calcification in an ex vivo murine aorta culture
12.
2022/03/10
IL-17A promotes vascular calcification in an ex vivo murine aorta culture
13.
2021/09
Barium‐induced pneumatosis intestinalis in a patient with anti‐synthetase syndrome
14.
2021/08/31
The "Ant-farm"-like Appearance of Restricted Lower Limb Vasculitis on Fluorodeoxyglucose-positron Emission Tomography: A Case Series
15.
2021/06/18
A tiger man: a case of muscular sarcoidosis
16.
2021/03
Severe oral stomatitis due to reactivation of herpes simplex virus type 1 in a methotrexate-treated patient with dermatomyositis.
17.
2021/01
Certolizumab pegol-induced immunoglobulin A vasculitis in a patient with rheumatoid arthritis
18.
2021/01
Tattoo skin reaction as a skin manifestation of systemic sarcoidosis
19.
2020/06/10
Effect of Angiotensin II on Bone Erosion and Systemic Bone Loss in Mice with Tumor Necrosis Factor-Mediated Arthritis
20.
2020/02
Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Should be Treated with Low-dose Prednisolone During Pembrolizumab Therapy
21.
2019/07/15
Japanese Spotted Fever: A Rare Cause of Arthritis
22.
2019/07
Tuberculous fasciitis in a patient with systemic lupus erythematosus.
23.
2019/05
Infection of Helicobacter cinaedi Should be Treated for an Adequate Duration with Combined Antibiotic Therapy: Author's Reply.
24.
2019/02/22
Tankyrase (PARP5) Inhibition Induces Bone Loss through Accumulation of Its Substrate SH3BP2.
25.
2019/01
Complete resolution of giant cell arteritis after tocilizumab monotherapy determined by positron emission tomography-CT
26.
2018/12
Bacteremia possibly caused by Helicobacter cinaedi and associated with painful erythema in rheumatoid arthritis with malignant lymphoma
27.
2018/10
Bladder carcinoma in situ in a patient with lupus cystitis
28.
2018/03
IgG4-related autoimmune pancreatitis complicated by splenic artery pseudoaneurysm.
29.
2018/03
Treatment of refractory rheumatoid pleural effusion with abatacept.
30.
2018/01
Pharmacological inhibition of tankyrase induces bone loss in mice by increasing osteoclastogenesis.
31.
2015/04
Development of aseptic subcutaneous abscess after tocilizumab therapy in a patient with SAPHO syndrome complicated by amyloid A amyloidosis
32.
2014/07
ACT-Ray study
Display 5 items
Display all(32)
■
Presentation
1.
2025/04/25
Clinical Relevance of Radial and Ulnar Artery Diameter Measurement Using Vascular Ultrasonography in Patients with Systemic Sclerosis （Speech，General）
2.
2022/09/07
“Ant-farm”-like Appearance; Characteristic F-18 Fluorodeoxyglucose Positron-Emission Tomographic Findings of Restricted （Poster notice，Keynote）
3.
2021/04/26
Excessive Angiotensin II exacerbates bone erosion in a murine tumor necrosis factor-mediated arthritis model （Speech）
4.
2020/10/24
Effect of Angiotensin II on Bone Erosion and Systemic Bone Loss in Mice with Tumor Necrosis Factor-Mediated Arthritis （Poster notice，General）
5.
2019/04/17
SH3BP2 gain-of-function mutation ameliorates lupus in B6.MRL-Faslpr mice （Speech，General）
6.
2018/04/27
Bone systemic administration of angiotensin II and its type 1 receptor gene deletion exacerbates erosive bone destruction in hTNF-transgenic arthritis mice （Speech，General）
7.
2018/04/27
Myostatin inhibition reduces bone loss in an unloading osteoporosis model （Speech，General）
8.
2018/04/27
Pharmacological inhibition of tankyrase induces bone loss in mice by increasing osteoclastgenesis （Speech，General）
9.
2018/04/27
SH3BP2 gain-of-function mutation alleviates lupus phenotypes in B6.MRL-Faslpr mice （Speech，General）
10.
2018/04/26
Functional analysis of the novel G58V mutation in the TNFRSF1A gene identified in a family with TNF receptor-associated periodic syndrome(TRAPS) （Speech，General）
11.
2017/11/07
SH3BP2 Gain-of-Function Mutation Ameliorates Lupus in B6.MRL-Faslpr Mice （Poster notice，General）
12.
2017/11/06
Angiotensin II Type I Receptor Deficiency Exacerbates Erosive Bone Destruction ofhTNF-Transgenic Arthritis Mice （Poster notice，General）
13.
2017/11/05
Functional Analysis of the Novel G58V Mutation in the TNFRSF1A Gene Identified in a Family with TNF Receptor-Associated Periodic Syndrome (TRAPS) （Poster notice，General）
14.
2017/11/05
Tankyrase/Wnt Inhibitor Upregulates Osteoclastogenesis and Osteoblastogenesis Via
SH3BP2 （Poster notice，General）
15.
2017/11/05
The Effect of Myostatin Inhibition on Bone Loss in Murine Osteoporosis Models （Poster notice，General）
16.
2017/09/18
Tankyrase/Wnt Inhibitor Upregulates Osteoclastogenesis and Osteoblastogenesis Via SH3BP2 （Poster notice，General）
17.
2017/04/21
Tankyrase regulates bone mass and osteoclastogenesis （Speech，General）
18.
2017/04/20
Angiotensin II exacerbates bone destruction in human TNF-transgenic arthritis mice （Speech，General）
19.
2017/04/20
The effect of myostatin inhibition on bone loss in murine osteoporosis models （Poster notice，General）
20.
2016/11/14
Tankyrase Regulates Osteoclastogenesis Via SH3BP2 （Poster notice，General）
21.
2016/11/13
Angiotensin II Exacerbates Bone Destruction in TNF-Transgenic Arthritis Mice （Poster notice，General）
22.
2016/04/23
Tankyrase Inhibitor Promotes Osteoclastogenesis by Enhancing SH3BP2 expression （Speech，General）
23.
2015/11/16
Tankyrase regulates osteoclastogenesis via SH3BP2 expression （Poster notice，General）
24.
2012/05/09
Biological agents for rheumatoid arthritis (RA) after the short term remission of methotrexate-associated lymphoproliferative disorders (MTX-LPD) （Speech，General）
Display 5 items
Display all(24)
